- Home
- CLDX vs MCRI Comparison
CLDX vs MCRI Comparison
Compare CLDX & MCRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- MCRI
- Stock Information
- Founded
- CLDX 1983
- MCRI 1972
- Country
- CLDX United States
- MCRI United States
- Employees
- CLDX N/A
- MCRI N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MCRI Hotels/Resorts
- Sector
- CLDX Health Care
- MCRI Consumer Discretionary
- Exchange
- CLDX Nasdaq
- MCRI Nasdaq
- Market Cap
- CLDX 1.8B
- MCRI 1.6B
- IPO Year
- CLDX 2008
- MCRI 1993
- Fundamental
- Price
- CLDX $25.77
- MCRI $82.34
- Analyst Decision
- CLDX Buy
- MCRI Hold
- Analyst Count
- CLDX 8
- MCRI 4
- Target Price
- CLDX $64.83
- MCRI $78.50
- AVG Volume (30 Days)
- CLDX 992.8K
- MCRI 117.3K
- Earning Date
- CLDX 11-06-2024
- MCRI 02-12-2025
- Dividend Yield
- CLDX N/A
- MCRI 1.45%
- EPS Growth
- CLDX N/A
- MCRI 2.59
- EPS
- CLDX N/A
- MCRI 4.52
- Revenue
- CLDX $9,976,000.00
- MCRI $515,859,000.00
- Revenue This Year
- CLDX N/A
- MCRI $5.05
- Revenue Next Year
- CLDX N/A
- MCRI $1.62
- P/E Ratio
- CLDX N/A
- MCRI $18.36
- Revenue Growth
- CLDX 128.55
- MCRI 4.46
- 52 Week Low
- CLDX $22.93
- MCRI $64.50
- 52 Week High
- CLDX $53.18
- MCRI $89.06
- Technical
- Relative Strength Index (RSI)
- CLDX 45.64
- MCRI 45.18
- Support Level
- CLDX $24.48
- MCRI $82.00
- Resistance Level
- CLDX $26.66
- MCRI $88.40
- Average True Range (ATR)
- CLDX 1.19
- MCRI 1.81
- MACD
- CLDX 0.03
- MCRI -0.61
- Stochastic Oscillator
- CLDX 35.73
- MCRI 12.04
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
About MCRI Monarch Casino & Resort Inc.
Monarch Casino & Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food & Beverage and Hotel Operations.